Introduction {#s0001}
============

Preterm birth affects 5--18% of pregnancies \[[@CIT0001]\] and is the leading cause of neonatal morbidity and mortality \[[@CIT0008]\]. One of every four women who deliver preterm has an intra-amniotic infection that is largely subclinical \[[@CIT0016]\]. Microbial-associated preterm labor is mediated by inflammatory processes that involve the production of cytokines such as interleukin (IL)-1 \[[@CIT0049]\], IL-6 \[[@CIT0032],[@CIT0053],[@CIT0054],[@CIT0056]\], IL-10 \[[@CIT0075],[@CIT0076]\], tumor necrosis factor-alpha (TNF-α) \[[@CIT0053],[@CIT0074],[@CIT0077]\], chemokines \[[@CIT0053],[@CIT0054],[@CIT0066],[@CIT0067],[@CIT0081]\], matrix-degrading enzymes \[[@CIT0096]\] and other inflammatory-related proteins \[[@CIT0056],[@CIT0107]\], which activate the common pathway of parturition \[[@CIT0001],[@CIT0003],[@CIT0125]\]. Multiple studies have shown that amniotic fluid (AF) IL-6 concentrations are superior to AF white blood cell (WBC) counts, glucose, Gram stain or equivalent to proteomic markers in identifying intra-amniotic infection and microbial invasion of the amniotic cavity (MIAC) \[[@CIT0058],[@CIT0060],[@CIT0071],[@CIT0128]\]. Moreover, even in the absence of demonstrable microorganisms in the amniotic cavity, an elevated AF IL-6 concentrations is associated with an increased risk of adverse pregnancy and neonatal outcomes in the context of preterm labor \[[@CIT0046],[@CIT0072],[@CIT0133]\], preterm prelabor rupture of the membranes (preterm PROM) \[[@CIT0137],[@CIT0138]\] and a short cervix \[[@CIT0139]\]. Thus, AF IL-6 concentrations have both diagnostic and prognostic value.

Currently, it usually takes hours to determine AF IL-6 concentrations, and the results are often unavailable in time to inform clinical decisions. A point of care (POC) test (lateral flow-based immunoassay) has been widely used in the settings of adult \[[@CIT0140]\] and neonatal sepsis \[[@CIT0141],[@CIT0142]\], as well as for other inflammation-related conditions \[[@CIT0143]\]. It was not until recently that such tests were used in obstetrics. In a pilot study, our group showed that AF IL-6 concentrations determined using a POC test were strongly correlated with those measured by conventional enzyme-linked immunosorbent assay (ELISA) (Spearman's ρ = 0.92) \[[@CIT0144]\]. Moreover, POC IL-6 test results can identify patients with preterm PROM who are destined to deliver preterm and/or have acute histological chorioamnionitis \[[@CIT0145]\].

In this study, we examined whether AF IL-6 concentrations, determined by a POC test, can identify patients with preterm labor with intact membranes who have intra-amniotic inflammation and/or infection, and/or deliver spontaneously before term, relative to the performance of concentrations determined by conventional ELISA.

Material and methods {#s0002}
====================

Study population {#s0003}
----------------

A retrospective cohort study was conducted by searching the clinical database and bank of biological samples of Wayne State University, the Detroit Medical Center and the Perinatology Research Branch of the *Eunice Kennedy Shriver* National Institutes of Child Health and Human Development (NICHD; Detroit, MI) to identify patients with a diagnosis of spontaneous preterm labor with intact membranes. Patients were included if they met the following criteria: (1) singleton gestation; (2) trans-abdominal amniocentesis performed between 20 and 35 weeks of gestation with microbiological studies; (3) available AF for the performance of microbiologic studies; and (4) neonatal outcomes were known. Patients were excluded from this study if they had placenta previa or if their fetus had a chromosomal or structural anomaly.

Patients with the diagnosis of preterm labor with intact membranes were counseled by their treating physicians about the potential value of identifying microorganisms in AF. Women who agreed to undergo an amniocentesis were asked to donate additional AF other than that required for clinical studies, and to allow collection of clinical information for research purposes. Further management of these patients was at the discretion of the attending physician. All patients provided written informed consent, and the use of biological specimens and clinical data for research purposes were approved by the Institutional Review Boards of NICHD and Wayne State University.

Biological samples and analysis {#s0004}
-------------------------------

AF was transported in a capped sterile syringe to the clinical laboratory where it was cultured for aerobic and anaerobic bacteria, including genital mycoplasmas. AF not required for clinical assessment was centrifuged for 10 min at 4 °C and stored at −70 °C until analysis. Evaluation of WBC count, glucose concentration and Gram stain of AF were also performed shortly after collection. The presence of intra-amniotic infection/inflammation was assessed by determination of AF IL-6 concentration by ELISA.

Clinical definitions {#s0005}
--------------------

Preterm labor was diagnosed by the presence of at least two regular uterine contractions every 10 min associated with cervical changes in patients with a gestational age between 20 and 36 6/7 weeks. Acute histologic chorioamnionitis was diagnosed according to previously described criteria \[[@CIT0148],[@CIT0149]\]. Funisitis was diagnosed when neutrophil infiltration was detected into the umbilical vessel walls or Wharton's jelly using previously reported criteria \[[@CIT0150]\]. Intra-amniotic inflammation was diagnosed when the AF IL-6 concentration was ≥2600 pg/ml (≥2.6 ng/ml), as determined by ELISA \[[@CIT0046],[@CIT0087],[@CIT0117],[@CIT0153]\]. MIAC was defined according to the results of AF culture. Intra-amniotic infection was defined as a combination of MIAC with intra-amniotic inflammation.

Analysis of AF samples for IL-6 concentrations {#s0006}
----------------------------------------------

AF IL-6 concentrations (pg/ml) were determined both by ELISA and the lateral flow-based immunoassay POC test. For ELISA, AF IL-6 concentrations were determined by immunoassays obtained from R&D Systems (Minneapolis, MN). The POC determination of AF IL-6 concentrations (pg/ml) was performed using a lateral flow-based immunoassay POC test (Milenia QuickLine® IL-6; Milenia Biotec, Bad Nauheim, Germany). The details and performance of ELISA \[[@CIT0037],[@CIT0046],[@CIT0053],[@CIT0057],[@CIT0060],[@CIT0153]\] and POC immunoassays have been previously described \[[@CIT0144]\]. The IL-6 POC test inter- and intra-assay coefficients of variations are 15.5% and 12.1%, respectively.

Study outcomes {#s0007}
--------------

The primary outcomes in this study are intra-amniotic inflammation and positive AF culture. Secondary outcomes include the occurrence of spontaneous preterm delivery (within 24 h, 48 d and 7 d of admission), spontaneous preterm delivery (\<28 and \<34 weeks of gestation) and the presence of placental lesions consistent with acute inflammation (acute histologic chorioamnionitis and/or acute funisitis). The relationships between acute histologic chorioamnionitis and AF IL-6 concentrations were examined in 55 patients who delivered within three days of amniocentesis. This interval was chosen to preserve a meaningful temporal relationship between the results of amniocentesis and placental pathology.

Statistical analysis {#s0008}
--------------------

The Kolmogorov--Smirnov test was used to assess normality of arithmetic data distributions. The Kruskal--Wallis and Mann--Whitney *U* tests were used to make comparisons among and between groups for arithmetic variables. Chi-square or Fisher's exact test were used for comparisons of categorical variables. Statistical analysis was performed using SPSS 19 (IBM Corp, Armonk, NY) and SAS 9.4 (Cary, NC). A *p* value \<0.05 was considered statistically significant.

Results {#s0009}
=======

Characteristics of the study population {#s0010}
---------------------------------------

A total of 136 women with preterm labor with intact membranes were included in this study. Their clinical characteristics are listed in [Table 1](#t0001){ref-type="table"}. The prevalence of MIAC and intra-amniotic inflammation was 16.2% (22/136) and 44.1% (60/136), respectively. Most of the participants had spontaneous preterm deliveries, specifically 22.8% (31/136) at \<28 weeks, 54% (74/136) at \<34 weeks and 64% (87/136) at \<37 weeks. The rates of spontaneous preterm delivery within 24 h, 48 h and 7 d were 33.8% (46/136), 43.4% (59/136) and 47.8% (65/136), respectively. The median (interquartile range) gestational age at amniocentesis was 30.9 (27--32.4) weeks. Of the 54 women who delivered within three days of the amniocentesis, and had placenta pathologic reports, 57.4% (31/54) had acute histologic chorioamnionitis, and most of their offspring were diagnosed with funisitis \[67.7% (21/31)\]. Table 1.Clinical characteristics of the study population.CharacteristicMedian (interquartile range) or percent (*n* = 136)Maternal age (years)24 (20--29)Nulliparity33.8% (46/136)Prior preterm delivery37.5% (51/136)Gestational age at amniocentesis (weeks)30.9 (27--32.4)Amniotic fluid glucose (mg/dl)24 (17--30.8)Amniotic fluid white blood cell (cell/m^3^)1.5 (0--13)Microbial invasion of the amniotic cavity (%)16.2% (22/136)Intra-amniotic inflammation (ELISA IL-6 ≥ 2600 pg/ml) (%)44.1% (60/136)Gestational age at delivery (weeks)33.3 (28.2--36.9)Interval from amniocentesis to delivery (d)8 (1--36.8)Spontaneous deliver within one day after amniocentesis (%)33.8% (46/136)Spontaneous deliver within two days after amniocentesis (%)43.4% (59/136)Spontaneous deliver within seven days after amniocentesis (%)47.8% (65/136)Spontaneous delivery at \<28 weeks of gestation (%)22.8% (31/136)Spontaneous delivery at \<34 weeks of gestation (%)54.4% (74/136)Spontaneous delivery at \<37 weeks of gestation (%)64% (87/136)Acute histologic chorioamnionitis (%)\*57.4% (31/54)Acute funisitis (%)\*38.9% (21/54)Acute inflammatory lesions of placenta (%)\*57.4% (31/54)[^1]

[Table 2](#t0002){ref-type="table"} lists the microorganisms identified by AF culture, gestational age at delivery, concentrations of IL-6 (by ELISA and POC test), AF inflammatory response and the type or absence of placental lesions consistent with acute inflammation in women with MIAC. The most frequent microorganism identified was *Ureaplasma urealyticum*, which was identified in 18% (4/22) of these women. Table 2.Clinical characteristics, amniotic fluid inflammatory response and acute inflammatory placental lesions in patients with microbial invasion of the amniotic cavity using cultivation techniques.No.OrganismsGA at delivery (weeks)AF glucose (mg/dl)AF WBC (cell/mm^3^)ELISA IL-6 (pg/ml)Point of care IL-6 (pg/ml)Acute histological chorioamnionitisAcute funisitis1.*Prevotella* spp., *Enterococcus faecalis*25^+1^10152 6373208NoNo2.*Mycoplasma hominis*331420172 3014613N/AN/A3.*Ureaplasma urealyticum*28^+6^13180943310 000Acute chorioamnionitisNo4.*Candida albicans*26^+3^102160201 2614448Necrotizing chorioamnionitisNo5.*Streptococcus agalactiae*2510493 6383575Necrotizing chorioamnionitisNo6.*Candida albicans, Lactobacillus* spp.33^+1^1043200 6263554Acute subchorionitisNo7.*Haemophilus influenza*30^+6^104092 0636467Necrotizing chorioamnionitisNecrotizing funisitis8.*Fusobacterium* spp., Gram-negative bacilli21^+6^191564317 6556228Subchorionic microabscessesNecrotizing funisitis9.Gram-negative bacilli21^+1^2066242 6995934Subacute chorioamnionitisUmbilical arteritis10.*Streptococcus agalactiae*25^+2^195248 8898208Acute chorioamnionitisUmbilical arteritis11.Gram-positive cocci22^+5^10125470 6265540Necrotizing chorioamnionitisUmbilical arteritis12.*Fusobacterium* spp., Gram-negative bacilli28^+1^122301 4263996Acute chorioamnionitisUmbilical arteritis13.*Ureaplasma urealyticum*331050085 9624628Acute chorioamnionitisUmbilical phlebitis/chorionic vasculitis14.*Streptococcus anginosus, Streptococcus mitis*22^+6^101073 2547246Acute chorioamnionitisUmbilical phlebitis/chorionic vasculitis15.*Bacteroides* spp., *Mobiluncus* spp., *Clostridium sporogenes*22^+4^10295517 8464748Necrotizing chorioamnionitisUmbilical phlebitis/chorionic vasculitis16.*Ureaplasma urealyticum*39^+2^1921274155NoNo17.Gram-negative bacilli26^+5^N/A610177910 000N/AN/A18.*Streptococcus* spp., *Gemella morbillorum*31^+6^1019207416796Necrotizing chorioamnionitisUmbilical arteritis19.*Candida albicans*32^+4^10129296 3344252Acute chorioamnionitisNecrotizing funisitis20.*Staphylococcus capitis*28^+6^2024360 5034374Subacute chorioamnionitisUmbilical arteritis21.*Mobiluncus* spp.321057076 8888144Acute chorioamnionitisUmbilical phlebitis/chorionic vasculitis22.*Ureaplasma urealyticum*34^+3^24024460Acute subchorionitisNo[^2]

The diagnostic performance of an AF IL-6 POC test for the identification of intra-amniotic inflammation {#s0011}
-------------------------------------------------------------------------------------------------------

Upon inspecting a receiver operating characteristic curve for the identification of intra-amniotic inflammation \[area under curve = 0.94 (0.90--0.99)\], a threshold of ≥745 pg/ml was selected for the POC test ([Figure 1](#F0001){ref-type="fig"}). [Table 3](#t0003){ref-type="table"} lists, at this cut-off, the POC test had a sensitivity of 93% and a specificity of 91%. Figure 1.Receiver operating characteristic curve that describes the performance of point of care test amniotic fluid interleukin-6 in the identification of intra-amniotic inflammation (determined by ELISA IL-6 ≥ 2600 pg/mL) (area under the curve for amniotic fluid IL-6 point of care test = 0.94; 95% confidence interval: 0.90--0.99, *p* \< 0.001). Table 3.Diagnostic performance of point of care AF IL-6 concentrations and ELISA AF IL-6 for identification of intra-amniotic infection and/or inflammation and placental lesions consistent with acute inflammation.  Point of care IL-6 test (cut-off 745 pg/ml)ELISA IL-6 (cut-off 2600 pg/ml)OutcomesDiagnostic performance% (*n*)95% CI% (*n*)95% CIIntra-amniotic inflammation \[44.1% (60/136)\]Sensitivity93.3 (56/60)(83.8--98)100% diagnostic performance. ELISA IL-6 is a gold standard test for the identification of intra-amniotic inflammation  Specificity90.8 (69/76)(82--96)   Positive predictive value88.9 (56/63)(78.4--95.4)   Negative predictive value94.5 (69/73)(86.6--98.5)   Positive likelihood ratio10.1 (93.3/9.2)(5--21)   Negative likelihood ratio0.07 (6.7/90.8)(0.03--0.2)   Microbial invasion of the amniotic cavity (MIAC) identified by culture \[16.3% (22/136)\]Sensitivity90.9 (20/22)(70.8--98.6)81.8 (18/22)(59.7--94.7) Specificity62.3 (70/114)(52.7--71.2)63.2 (71/114)(53.6--72.0) Positive predictive value31.8 (20/63)(20.6--44.7)30.0 (18/60)(18.9--43.2)  Negative predictive value97.3 (71/73)(90.4--99.6)94.7 (71/76)(87.1--98.5) Positive likelihood ratio2.41 (90.9/37.7)(1.8--3.2)2.2 (81.8/36.8)(1.6--3.0)  Negative likelihood ratio0.15 (9.1/62.3)(0.04--0.6)0.3 (18.2/63.2)(0.1--0.7) Acute inflammatory lesions of placenta (chorioamnionitis or funisitis) \[only patients who delivered within three days after amniocentesis were included \[57.4% (31/54)\]\]Sensitivity93.6 (29/31)(78.5--99)93.6 (29/31)(78.5--99.0) Specificity43.5 (10/23)(23.2--65.5)52.2 (12/23)(30.6--73.2) Positive predictive value69.1(29/42)(52.9--82.3)72.5 (29/40)(56.1--85.4) Negative predictive value83.3 (10/12)(51.6--97.4)85.7 (12/14)(57.2--97.8) Positive likelihood ratio1.7 (93.6/56.5)(1.1--2.4)2.0 (93.6/47.8)(1.3--3.03)  Negative likelihood ratio0.15 (6.4/43.5)(0.04--0.6)0.12 (6.4/52.2)(0.03--0.5)Acute funisitis \[only patients who delivered within three days after amniocentesis were included \[38.9% (21/54)\]\]Sensitivity100 (21/21)(83.8--100)95.2 (20/21)(76.1--99.2) Specificity36.4 (12/33)(20.4--54.9)39.4 (13/33)(22.9--57.9) Positive predictive value50.0 (21/42)(34.2--65.8)50.0 (20/40)(33.8--66.2) Negative predictive value100.0 (12/12)(73.4--100)92.9 (13/14)(66.1--98.8) Positive likelihood ratio1.57 (100/63.6)(1.2--2)1.6 (95.2/60.6)(1.2--2.1)  Negative likelihood ratio0--0.12 (4.8/39.4)(0.02--0.8)[^3]

Of seven women with negative ELISA AF IL-6 tests who had positive POC test results, six (85%) delivered within two days of amniocentesis at \<34 weeks of gestation. Two of these women also had positive AF cultures: one had *Streptococcus* spp./*Gemella morbillorum* in addition to placental lesions consistent with acute inflammation; the other had Gram-negative bacilli, but placental histopathology was not available. On the other hand, four patients had positive ELISA AF IL-6 test results, yet the results of the POC test were negative. Two of these four patients delivered at term, none had a positive AF culture, and one had an AF IL-6 concentration above the cutoff used to define intra-amniotic inflammation (2609 pg/ml; determined by ELISA). This patient did not have placental lesions consistent with acute inflammation.

The diagnostic performance of an AF IL-6 POC test for the identification of MIAC and acute inflammatory lesions of placenta {#s0012}
---------------------------------------------------------------------------------------------------------------------------

[Table 3](#t0003){ref-type="table"} lists the performance of the POC test in identifying patients with MIAC and those with placental lesions consistent with acute inflammation was equivalent to that of conventional ELISA. Among patients with MIAC, 18.2% (4/22) had negative ELISA IL-6 results ([Table 2](#t0002){ref-type="table"}). However, POC AF IL-6 was elevated in two of these four patients. One of these patients had acute histologic chorioamnionitis and funisitis; therefore, this implied true intra-amniotic infection. The placental pathology report was not available for the other patient.

Of note, one of the two patients with MIAC who had negative AF IL-6 test results for both assays (POC and ELISA) delivered at term and did not have placental lesions consistent with acute inflammation, suggesting the possibility of contamination \[i.e. false-positive AF culture (*U. urealyticum*)\].

The diagnostic performance of an AF IL-6 POC test for the identification of impending preterm delivery {#s0013}
------------------------------------------------------------------------------------------------------

[Table 4](#t0004){ref-type="table"} lists the performance of the POC and ELISA AF IL-6 tests in identifying women who had spontaneous preterm deliveries. Both tests had equivalent positive likelihood ratios in identifying patients who had a spontaneous preterm delivery within one day of amniocentesis, or those who would subsequently deliver spontaneously at \<28 weeks of gestation. Sensitivity and specificity were each marginally higher for the POC test than for the ELISA in identifying women who would deliver spontaneously within either two or seven days of amniocentesis. In contrast, sensitivity was slightly higher, whereas specificity was slightly lower, when comparing the performance of the POC test to that of the ELISA for the identification of spontaneous preterm delivery at \<34 weeks of gestation. Yet, confidence intervals for estimates characterizing the diagnostic performance of the POC test overlapped with those of the ELISA test, indicating statistically equivalent performance in assessing the risk of spontaneous preterm delivery. Table 4.Diagnostic performance of point of care AF IL-6 concentrations and ELISA AF IL-6 for identification of patients with spontaneous preterm delivery.  Point of care IL-6 test (cut-off 745 pg/ml)ELISA IL-6 (cut-off 2600 pg/ml)OutcomesDiagnostic performance% (*n*)95% CI% (*n*)95% CISpontaneous preterm delivery within one day after amniocentesis \[33.8% (46/136)\]Sensitivity84.8 (39/46)(71.1--93.6)78.3 (36/46)(63.6--89.0)Specificity73.3 (66/90)(63--82)73.3 (66/90)(63--82.1)Positive predictive value62 (39/63)(48.8--73.9)60.0 (36/60)(46.5--72.4) Negative predictive value90.4 (66/73)(81.2--96.0)86.8 (66/76)(77.1--93.5) Positive likelihood ratio3.2 (84.4/26.7)(2.2--4.6)2.9 (78.3/26.7)(2.0--4.3)  Negative likelihood ratio0.21 (15.2/73.3)(0.1--0.4)0.3 (21.7/73.3)(0.2--0.5) Spontaneous preterm delivery within two days after amniocentesis \[43.4% (59/136)\]Sensitivity79.7 (47/59)(67.2--89)71.2 (42/59)(57.9--82.2) Specificity79.2 (61/77)(68.5--87.6)76.6 (59/77)(65.6--85.5) Positive predictive value74.6 (47/63)(62.1--84.7)70.0 (42/60)(56.8--81.2.5)  Negative predictive value83.6 (61/73)(73--91.2)77.6 (59/76)(66.6--86.4) Positive likelihood ratio3.8 (79.7/20.8)(2.4--6)3.1 (71.2/23.4)(2--4.7)  Negative likelihood ratio0.3 (20.3/79.2)(0.2--0.4)0.4 (28.8/76.6)(0.3--0.6) Spontaneous preterm delivery within seven days after amniocentesis \[47.8% (65/136)\]Sensitivity78.5 (51/65)(66.5--87.7)72.3 (47/65)(59.8--82.7) Specificity83.1 (59/71)(72.3--90.9)81.69 (58/71)(70.7--89.9) Positive predictive value81 (51/63)(69.1--89.7)78.3 (47/60)(65.8--87.9)  Negative predictive value80.8 (59/73)(69.9--89.1)76.3 (58/76)(65.2--85.3) Positive likelihood ratio4.6 (78.5/16.9)(2.7--7.9)4.0 (72.3/18.31)(2.4--6.6)  Negative likelihood ratio0.3 (21.5/83.1)(0.16--0.4)0.3 (27.7/81.69)(0.2--0.5) Spontaneous preterm delivery \<28 weeks \[22.8% (31/136)\]\*Sensitivity87.1 (27/31)(70--96.3)83.9 (26/31)(66.3--94.5) Specificity75.0 (6/8)(35.1--96.7)75.0 (6/8)(35.1--96.1)  Positive predictive value93.1 (27/29)(77.2--99.0)92.9 (26/28)(76.5--98.9) Negative predictive value60.0 (6/10)(26.4--87.6)54.6 (6/11)(23.5--83.1)  Positive likelihood ratio3.5 (87.1/25)(1.04--11.7)3.4 (83.9/25)(1.0--11.3)  Negative likelihood ratio0.2 (12.9/75)(0.06--0.5)0.22 (16.1/75)(0.09--0.53) Spontaneous preterm delivery \<34 weeks \[54.4% (74/136)\]†Sensitivity77.03 (57/74)(65.8--86.01)72.97 (54/74)(61.4--82.6) Specificity71.43 (5/7)(29.3--95.5)85.71 (6/7)(42.2--97.6)  Positive predictive value96.6 (57/59)(88.3--99.5)98.2 (54/55)(90.2--99.7) Negative predictive value22.7 (5/22)(7.9--45.4)23.08 (6/26)(90.3--99.7)  Positive likelihood ratio2.7 (77.03/28.57)(0.8--8.8)5.1 (72.97/14.29)(0.19--0.51)  Negative likelihood ratio0.32 (22.97/71.43)(0.17--0.6)0.32 (27.03/85.71)(0.19--0.51) [^4]

Discussion {#s0014}
==========

Principal findings of the study: (1) AF IL-6 concentrations determined by a POC test have high sensitivity (93%) and specificity (91%) for the identification of intra-amniotic inflammation, by using a threshold of 745 pg/ml and (2) the POC test and ELISA for IL-6 determination perform similarly in identifying patients with MIAC, acute inflammatory lesions of placenta and risk of impending spontaneous preterm delivery in patients with preterm labor with intact membranes.

AF IL-6 POC test for the identification of intra-amniotic inflammation and impending preterm delivery {#s0015}
-----------------------------------------------------------------------------------------------------

Compelling evidence indicates that patients with intra-amniotic inflammation are at greater risk for impending preterm delivery and other adverse outcomes, even without identifiable microorganisms \[[@CIT0046],[@CIT0072],[@CIT0133],[@CIT0158]\]. We have previously demonstrated that sterile intra-amniotic inflammation (inflammatory process in which microorganisms are neither detected by cultivation nor molecular methods) is more common than microbial-associated intra-amniotic inflammation in patients with preterm labor and intact membranes \[[@CIT0072],[@CIT0134]\], asymptomatic sonographic short cervix \[[@CIT0139]\] and preterm PROM \[[@CIT0138]\]. Moreover, we have shown that sterile intra-amniotic inflammation is associated with adverse pregnancy outcomes; hence the importance of identifying patients with intra-amniotic inflammation \[[@CIT0072],[@CIT0134],[@CIT0139]\].

In this study, we have demonstrated that a POC AF IL-6 test has high sensitivity and specificity in the identification of intra-amniotic inflammation and spontaneous preterm delivery. While its performance in identifying infection/inflammation-related obstetrical outcomes was comparable to that of AF IL-6 concentrations determined by ELISA, the POC assay can yield results within 20 min. Hence, unlike conventional ELISA, POC AF IL-6 results can be available in time to inform clinical decisions, similar to a rapid matrix metalloproteinase-8 (MMP-8) test, which has been shown to identify intra-amniotic infection/inflammation in patients with preterm labor and intact membranes with \>80% sensitivity and \>90% specificity \[[@CIT0103]\]. Furthermore, the MMP-8 test was found to be useful in the identification of intra-amniotic inflammation in patients with preterm PROM \[[@CIT0104]\], MIAC in patients at risk for preterm delivery \[[@CIT0159]\] and funisitis in patients with preterm delivery \[[@CIT0160]\].

It is interesting that six of seven patients with positive POC test and negative ELISA results had early spontaneous preterm deliveries (\<34 weeks) within two days of amniocentesis. This suggests that the POC test contributes additional risk information beyond that provided by conventional ELISA. It is further noteworthy that two of the four patients with negative POC and positive ELISA test results delivered at term, one of them did not have placental lesions consistent with acute inflammation, and this patient had a positive ELISA result (2609 pg/ml).

In a prior study, we showed that AF IL-6 concentrations determined by a POC test were on an average 30% lower than that determined by conventional ELISA. Thus, it is not surprising that a lower AF IL-6 cut-off was selected for the POC to identify patients with intra-amniotic inflammation in this study (≥745 pg/ml). Kacerovsky et al. proposed a higher cut-off (1000 pg/ml) in a study using the same assay to determine AF IL-6 concentrations among women with preterm PROM for the identification of MIAC (or the combination of MIAC with acute histological chorioamnionitis) \[[@CIT0146]\]. Other investigators who used a POC test to determine IL-6 concentrations in vaginal fluid from women with preterm PROM have reported high negative predictive value for the detection of intra-amniotic inflammation, comparable to that observed in our study (97.4% versus 94.5%) \[[@CIT0147]\]. Yet, the positive predictive value in our study was higher than that of vaginal fluid IL-6 concentration POC test (88.9% versus 50%). Vousden et al. reported the use of POC IL-6 in vaginal fluid to determine pregnancy outcomes in asymptomatic high-risk patients of preterm birth \[[@CIT0145]\]. Using a cut-off of 56 pg/ml, vaginal fluid IL-6 concentrations had 81% sensitivity and 65% specificity to identify patients who delivered \<28 weeks of gestation \[[@CIT0145]\]. This diagnostic performance is slightly lower than that of POC AF IL-6 in this study. The optimal cutoff value is to be determined in accordance with regard to risk/benefit ratios for specific interventions.

Strengths and limitations {#s0016}
=========================

The strengths of this study include: (1) we included a homogenous group of patients with preterm labor with intact membranes rather than including patients with preterm pre-labor rupture of membranes who have a higher prevalence of intra-amniotic infection/inflammation and (2) the POC test was not used to inform treatment. A limitation is that we used cultivation technique to identify microorganisms in the amniotic cavity. Thus, non-culturable bacteria, which could have been identified by molecular microbiologic techniques, may be not able to be detected.

Conclusion {#s0017}
==========

A POC AF IL-6 test can identify intra-amniotic inflammation as determined by ELISA in women with preterm labor and intact membranes, and it also performs equivalently in identifying those who subsequently deliver spontaneously before term. Further studies are warranted to determine whether POC AF IL-6 results can inform treatment decisions sufficient to improve pregnancy outcomes in such patients.
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[^1]: Data presented as median (interquartile range) or % (*n*).

    Acute inflammatory lesions of placenta include acute histologic chorioamnionitis and acute funisitis.

    \*Included only patients who had interval from amniocentesis to delivery \< 3 d (*n* = 59). Among these patients, placenta histology reports were not available in four patients, and placental histopathology reports were not available in 13/136 patients.

[^2]: N/A: results were not available; WBC, white blood cell count; AF, amniotic fluid; acute subchorionitis/chorionitis = acute histologic chorioamnionitis stage 1; acute chorioamnionitis = acute histologic chorioamnionitis stage 2; necrotizing chorioamnionitis and subacute chorioamnionitis = acute histologic chorioamnionitis stage 3; subchorionic microabscesses = severe acute histologic chorioamnionitis; umbilical phlebitis/chorionic vasculitis = acute funisitis stage 1; umbilical arteritis = acute funisitis stage 2; necrotizing funisitis = acute funisitis stage 3.

[^3]: CI: confidence interval.

[^4]: CI: confidence interval.

    \*The analysis was performed only in patients who had amniocentesis at \<28 weeks (*n* = 39).

    †The analysis was performed only in patients who had amniocentesis at \<34 weeks (*n* = 81).
